McKesson Ventures

McKesson Ventures is the venture capital arm of McKesson Corporation, established in December 2014 and headquartered in San Francisco, California. The firm specializes in investing in early-stage and growth-stage companies within the healthcare sector, particularly those focused on digital health and technology-enabled services. McKesson Ventures aims to support entrepreneurs in creating efficient healthcare delivery systems that benefit various stakeholders in the healthcare economy, including pharmaceutical companies, providers, and patients. The firm typically makes minority investments ranging from $20 million to $25 million in companies that emphasize direct-to-consumer healthcare and innovative clinical services.

Jennifer Carter

Partner and Vice President Venture Operations

Priyanka Kanal

Associate

Tom Rodgers

EVP, Chief Strategy Officer

Dave Schulte

SVP, Managing Director

Carrie Williams

Principal

Brian Zhu

Senior Associate

109 past transactions

Lynx

Series A in 2025
Lynx is a fintech platform focused on healthcare, providing an API-connected service that enables businesses to incorporate payments, banking, and e-commerce seamlessly. Lynx FinHealth is a contemporary financial solution tailored to current healthcare demands, explicitly stating that it is not a bank. Instead, banking services and debit cards are offered through partnering banks.

PRISM Vision Group

Acquisition in 2025
PRISM Vision Group is a healthcare company that specializes in comprehensive support services to eye care organizations. It specializes in advanced surgical, injection, and medical approaches for patients with all types of retinal problems.

Bluenote Health

Venture Round in 2024
Bluenote Health operates as an AI platform for life sciences.

Core Ventures

Acquisition in 2024
Core Ventures is a business and administrative services corporation founded by the Florida Cancer Specialists & Research Institute.

Atropos Health

Series B in 2024
Atropos Health is a technology company based in Palo Alto, California, founded in 2019. It specializes in developing a digital prognostogram platform, known as the Atropos Evidence Platform, which transforms health data into actionable real-world evidence. By integrating electronic medical record (EMR) data, the platform generates digital evidence tailored to individual patient outcomes. This enables healthcare institutions, life science companies, and researchers to utilize previously siloed EMR data effectively. The platform aims to close evidence gaps in healthcare, enhance clinical outcomes through data-driven care, and accelerate research initiatives. Atropos Health serves caregivers, healthcare organizations, and risk-bearing entities, contributing to advancements in evidence-based healthcare.

Compile

Acquisition in 2024
Actionable insights from the most accurate, detailed network of patients and providers. Compile’s Healthgraph offers an unprecedented level of visibility to the treatment of patients and the business of healthcare. Healthgraph is built using 70% of all medical claims from 2015 to today, along with a majority sample of Rx claims over the same timeframe. This real-world data is cross-linking this with every conceivable public data source. Pharmaceutical and medical device companies can now better understand where the relevant patients are being seen, the healthcare professionals (HCPs) that are treating them, the treatment protocols and how those HCPs are related to each other and to practices, healthcare organizations (HCOs) and integrated delivery networks (IDNs) throughout the U.S. Healthgraph can help answer many challenging questions across the commercial lifecycle from the early market research pre-launch, to launch plans and beyond.

Inbound Health

Series B in 2023
Inbound Health is a company that specializes in enabling health systems and health plans to implement hospital-at-home and skilled nursing-at-home programs. It has developed a health platform that utilizes AI-based technology to provide models for delivering hospital and skilled nursing facility-level care in patients' homes. This innovative approach allows for safe, predictive care that is both scalable and integrated, ensuring that patients receive real-time oversight and high-quality care in a familiar environment.

RxLightning

Series A in 2023
RxLightning is a digital platform focused on improving access to specialty medications by automating and streamlining the enrollment process. The company addresses the complexities associated with starting patients on specialty therapies across various fields, including addiction medicine, cardiology, endocrinology, and dermatology. By digitizing manual procedures, RxLightning reduces the burden of paperwork and enhances communication among healthcare providers, ultimately accelerating patients' speed to therapy. This innovative approach allows for a more efficient and effective management of specialty prescriptions, benefiting both healthcare professionals and patients alike.

Glide Health

Acquisition in 2023
Glide Health is a health technology company that specializes in providing intelligent financial solutions for healthcare organizations. Utilizing proprietary AI and machine learning, Glide Health enhances revenue and cash flow by integrating operations across various healthcare entities. The Glide Intelligence platform offers predictions and recommendations to optimize the revenue cycle, including patient registration, prior authorization, claim submission, denial management, and collections. It analyzes financial and clinical data in real time, generating actionable insights based on current trends. Additionally, Glide Mobile Health offers a centralized mobile solution that allows patients and healthcare professionals to access and manage patient information from various devices. This platform enables seamless collaboration, allowing patients to document their medical history and interact with healthcare providers while ensuring the privacy and security of their records. By improving compatibility among health information systems, Glide Health enhances the quality of care and facilitates better coordination in local and global healthcare settings. Overall, Glide Health aims to streamline healthcare operations and improve patient outcomes through innovative technology.

Glide Health

Acquisition in 2023
Glide Health is a health technology company that specializes in providing intelligent financial solutions for healthcare organizations. Utilizing proprietary AI and machine learning, Glide Health enhances revenue and cash flow by integrating operations across various healthcare entities. The Glide Intelligence platform offers predictions and recommendations to optimize the revenue cycle, including patient registration, prior authorization, claim submission, denial management, and collections. It analyzes financial and clinical data in real time, generating actionable insights based on current trends. Additionally, Glide Mobile Health offers a centralized mobile solution that allows patients and healthcare professionals to access and manage patient information from various devices. This platform enables seamless collaboration, allowing patients to document their medical history and interact with healthcare providers while ensuring the privacy and security of their records. By improving compatibility among health information systems, Glide Health enhances the quality of care and facilitates better coordination in local and global healthcare settings. Overall, Glide Health aims to streamline healthcare operations and improve patient outcomes through innovative technology.

Perceiv AI

Seed Round in 2022
Perceiv AI is a healthcare company focused on precision medicine, utilizing advanced artificial intelligence to enhance patient outcomes. The company specializes in identifying suitable subjects for clinical trials, helping pharmaceutical firms improve their chances of success by analyzing complex data related to heterogeneous diseases. Perceiv's platform integrates various types of longitudinal data, including imaging, genetic, phenotypic, and clinical variables, to characterize individuals more accurately. This approach enables healthcare organizations to target individuals at risk of disease progression, particularly in areas such as age-related conditions, including Alzheimer's disease and cardiovascular issues. Through its innovative AI-driven solutions, Perceiv aims to facilitate the development of effective therapies and improve the efficacy of clinical trials.

OncoHealth

Private Equity Round in 2022
OncoHealth specializes in oncology benefits management, offering a range of services designed to support health plans, employers, providers, patients, and life science researchers in managing the complexities of cancer care. Its offerings include prior authorization services, clinical decision support, physician education, expert peer review, and oncology network evaluation and optimization consulting. Additionally, OncoHealth provides MATIS, a clinical decision support software that employs evidence-based analytics for evaluating cancer treatment and benefits management in the United States and Puerto Rico. The company aims to alleviate the physical, mental, and financial burdens associated with cancer through technology-driven solutions and real-world data. Founded in 2009, OncoHealth is headquartered in Atlanta, Georgia, with an additional location in Plantation, Florida.

CancerIQ

Series B in 2022
CancerIQ is a precision health technology company that provides a platform designed to assist healthcare providers in identifying and managing patients at high risk for cancer. The platform features predictive analytics and screening tools to help clinicians detect at-risk patients early. It includes a comprehensive library of evidence-based guidelines and risk models, which aids providers in interpreting data and guiding patients toward appropriate genetic testing, screening, and treatment interventions. Additionally, CancerIQ offers a digital genetic test ordering system and patient management tools, enhancing clinician efficiency and improving patient outcomes by facilitating early cancer detection and adherence to evidence-based care strategies.

Koneksa

Series C in 2022
Koneksa Health Inc. is a healthcare data analytics company focused on enhancing clinical studies and disease research through the use of remotely generated patient data. The company's software, Koneksa Compare, facilitates the collection, visualization, and analysis of patient-generated data, incorporating emerging technologies such as bio-sensors, activity trackers, and mobile-based questionnaires. This platform allows pharmaceutical and biotech companies, as well as academic researchers, to make informed decisions and regulatory claims based on objective data. Koneksa also provides biometric devices that generate electronic clinical outcome assessments and offers a dashboard for monitoring patient engagement, which includes reminders for study subjects. Founded in 2013 and headquartered in New York, Koneksa has an additional office in London, United Kingdom.

Reimagine Care

Series A in 2022
Reimagine Care is a healthcare company focused on enhancing community-based oncology care through technology-enabled services. Established in 2020 and based in Nashville, Tennessee, the company seeks to improve the affordability, accessibility, and patient-centricity of cancer care. By collaborating with healthcare systems and independent oncology practices, Reimagine Care supports value-based oncology care delivery. Their approach involves providing the necessary personnel, processes, and a comprehensive technology platform that facilitates the effective and scalable delivery of high-quality cancer care at various locations, including patients' homes. This model aims to enable patients to receive treatment and supportive care in a more convenient and cost-effective manner.

Lightship

Series C in 2021
Lightship is a company founded in 2018 that focuses on enhancing access, choice, and equity in clinical trials through decentralized and hybrid clinical services. By leveraging innovations in digital health and technology, Lightship aims to transform the clinical research landscape by improving patient experiences, retention, and trial diversity. The company moves beyond traditional research centers to make clinical studies more accessible, allowing medical research organizations to overcome the barriers and inefficiencies associated with conventional clinical trial models. Its mission centers on placing patients at the forefront, ensuring that clinical research is designed to meet the needs of diverse populations globally.

IVX Health

Series F in 2021
IVX Health specializes in providing infusion and injection therapy for patients with complex chronic conditions, including rheumatoid arthritis, Crohn's disease, multiple sclerosis, lupus, and psoriasis. The company operates clinics that offer biologic injections and infusions in a private, comfortable environment. Located within the communities they serve, IVX Health centers prioritize convenience with flexible scheduling options, including evenings and weekends. Each center features private suites designed for patient comfort, equipped with high-speed Wi-Fi, flat-screen TVs, and recliners that accommodate guests. In certain locations, IVX Health operates under the brand Infusion Express, serving areas such as Kansas City, Philadelphia, Chicago, and San Francisco.

AllStripes

Series B in 2021
AllStripes is a healthcare technology company focused on accelerating the development of treatments for rare diseases. The company has created a platform that produces regulatory-ready evidence to support rare disease research and drug development. This platform operates as a two-sided network where patients with rare diseases and advocacy groups contribute valuable information, while life science companies utilize this data to identify new drug candidates. Additionally, AllStripes offers a patient application that allows individuals to engage in treatment research online and leverage their own medical data, fostering a collaborative environment aimed at advancing medical research for rare conditions.

Evidation Health

Series E in 2021
Evidation Health, Inc. specializes in developing digital tools and technologies for healthcare data analytics. The company connects digital health firms with healthcare providers and payers through its advanced platform, which transforms everyday behavior data from various sources, including sensors and devices, into actionable insights regarding health and disease. Its products include a Data Platform that analyzes this high-frequency behavior data and a technology-enabled service called Studies, which facilitates real-world research to support clinical and commercial efforts. By focusing on the interplay between everyday behaviors and health outcomes, Evidation aims to empower individuals and healthcare companies to improve health management outside traditional clinical settings. Founded in 2012 and headquartered in San Mateo, California, the company also operates additional offices in San Francisco and Santa Barbara.

M2Gen

Private Equity Round in 2021
M2Gen is a health informatics solutions company established in 2006 at the Moffitt Cancer Center in Tampa, Florida. The company specializes in advancing precision medicine by integrating and analyzing clinical and molecular data. Its integrated platform helps identify patient susceptibility to diseases, predict drug responses, and match patients with optimal therapies for better treatment outcomes. M2Gen also offers a portfolio designed for biopharmaceutical companies to discover new targets and biomarkers, enhance clinical trial design and enrollment, and conduct post-market analysis. One of its key initiatives is the Total Cancer Care Protocol, which studies patients throughout their lifetime, and the ORIEN Avatar Research Program, which focuses on individuals with advanced disease and limited treatment options. M2Gen operates as a subsidiary of the H. Lee Moffitt Cancer Center & Research Institute.

Aspen RxHealth

Series B in 2021
Aspen RxHealth is a Tampa, Florida-based company that provides an online platform designed to connect licensed pharmacists with patients requiring enhanced medication services. Through its app-based technology, Aspen RxHealth facilitates direct patient care by matching pharmacists to patients based on various social and clinical criteria, such as language and medication regimens. This platform enables health plans and providers to link their patients with a community of pharmacists who can deliver clinical services tailored to individual needs. The services offered include comprehensive medication reviews and targeted medication interventions, all aimed at optimizing communication and improving patient care.

Clinical Ink

Venture Round in 2020
Clinical Ink, Inc. specializes in providing eSource and patient engagement solutions designed to streamline clinical research for sites, sponsors, contract research organizations (CROs), and patients. Founded in 2006 and headquartered in Horsham, Pennsylvania, with additional offices in Winston-Salem and Cary, North Carolina, Philadelphia, Pennsylvania, and Cambridge, Massachusetts, the company offers a suite of innovative tools including SureSource, an electronic source platform that captures data and documents at the site level, and Lunexis ePRO+, which facilitates patient participation in studies. Additionally, Clinical Ink provides CentrosHealth, a patient engagement platform that includes configurable apps to enhance patient involvement and compliance throughout clinical trials. The company aims to improve clinical trial workflows by integrating electronic data capture and reducing manual processes, ensuring that clients have access to high-quality, validated data.

Vineti

Series C in 2020
Vineti, Inc. is a technology company that specializes in developing solutions for the therapeutic delivery of personalized medicine, particularly focusing on cell and gene therapies. Founded in 2016 and headquartered in San Francisco, California, with additional offices in Bethesda, Maryland, and Yerevan, Armenia, Vineti offers a cloud-based platform known as the Personalized Therapy Management (PTM) platform. This platform streamlines and automates patient-centric supply chains, facilitating the efficient management of operations, manufacturing, quality control, and regulatory compliance for advanced therapies, including CAR-T cell therapies for late-stage cancer. Vineti's solutions aim to enhance patient access to life-saving treatments while addressing the challenges faced by patients, healthcare providers, pharmaceutical companies, and regulators in the commercialization of personalized medicine. By providing tools for supply chain orchestration and maintaining an audit trail for the handling of cell products, Vineti positions itself as a critical player in the evolving landscape of personalized therapeutics.

Augmedix

Private Equity Round in 2020
Augmedix, Inc. is a healthcare technology company based in San Francisco, California, with additional offices in Menlo Park and Dhaka, Bangladesh. Founded in 2012, Augmedix specializes in remote medical documentation and live clinical support through its cloud-based platform. The application transforms natural clinician-patient conversations into organized medical notes in real time, allowing healthcare providers to focus more on patient care and reducing the administrative burden associated with electronic health record documentation. By partnering with hospitals and health systems, Augmedix enhances clinical efficiency and decision-making, ultimately improving operational and financial outcomes. The platform is designed for use by both large healthcare organizations and individual practitioners, charging service fees for access to its remote documentation and clinical support services.

Koneksa

Series B in 2020
Koneksa Health Inc. is a healthcare data analytics company focused on enhancing clinical studies and disease research through the use of remotely generated patient data. The company's software, Koneksa Compare, facilitates the collection, visualization, and analysis of patient-generated data, incorporating emerging technologies such as bio-sensors, activity trackers, and mobile-based questionnaires. This platform allows pharmaceutical and biotech companies, as well as academic researchers, to make informed decisions and regulatory claims based on objective data. Koneksa also provides biometric devices that generate electronic clinical outcome assessments and offers a dashboard for monitoring patient engagement, which includes reminders for study subjects. Founded in 2013 and headquartered in New York, Koneksa has an additional office in London, United Kingdom.

Pharmapacks

Private Equity Round in 2020
Pharmapacks is an e-commerce company based in Islandia, New York, that specializes in health and beauty products, including multivitamins, nutritional supplements, personal care, and pet care items. Founded in 2010 as a brick-and-mortar pharmacy, Pharmapacks now operates a proprietary tech platform that provides brands with comprehensive logistics, fulfillment, marketing, and sales solutions. The company sells products directly to consumers via its own website, Pharmapacks.com, as well as through partner sites such as Amazon, Walmart.com, and eBay. Pharmapacks also serves as a launchpad for emerging brands, offering selected lesser-known brands access to its extensive consumer base and e-commerce capabilities. This strategic approach helps to connect consumers with brands while maintaining competitive pricing in the online marketplace.

Evidation Health

Series D in 2020
Evidation Health, Inc. specializes in developing digital tools and technologies for healthcare data analytics. The company connects digital health firms with healthcare providers and payers through its advanced platform, which transforms everyday behavior data from various sources, including sensors and devices, into actionable insights regarding health and disease. Its products include a Data Platform that analyzes this high-frequency behavior data and a technology-enabled service called Studies, which facilitates real-world research to support clinical and commercial efforts. By focusing on the interplay between everyday behaviors and health outcomes, Evidation aims to empower individuals and healthcare companies to improve health management outside traditional clinical settings. Founded in 2012 and headquartered in San Mateo, California, the company also operates additional offices in San Francisco and Santa Barbara.

OncoHealth

Series C in 2020
OncoHealth specializes in oncology benefits management, offering a range of services designed to support health plans, employers, providers, patients, and life science researchers in managing the complexities of cancer care. Its offerings include prior authorization services, clinical decision support, physician education, expert peer review, and oncology network evaluation and optimization consulting. Additionally, OncoHealth provides MATIS, a clinical decision support software that employs evidence-based analytics for evaluating cancer treatment and benefits management in the United States and Puerto Rico. The company aims to alleviate the physical, mental, and financial burdens associated with cancer through technology-driven solutions and real-world data. Founded in 2009, OncoHealth is headquartered in Atlanta, Georgia, with an additional location in Plantation, Florida.

Amwell

Series C in 2020
Amwell is a telehealth platform based in the United States that connects healthcare providers, insurers, patients, and innovators to enhance access to affordable and high-quality medical care. Founded in 2006 and headquartered in Boston, the company offers a comprehensive platform to address various telehealth needs, including urgent and acute care, post-acute care, chronic care management, and healthy living. With over a decade of experience, Amwell serves more than 240 health systems, comprising 2,000 hospitals and 55 health plan partners, and reaches over 150 million individuals, including 36,000 employers. The platform supports both on-demand and scheduled consultations, providing solutions for primary care, specialty consults, and chronic care programs like musculoskeletal and dermatology care.

Lightship

Series B in 2020
Lightship is a company founded in 2018 that focuses on enhancing access, choice, and equity in clinical trials through decentralized and hybrid clinical services. By leveraging innovations in digital health and technology, Lightship aims to transform the clinical research landscape by improving patient experiences, retention, and trial diversity. The company moves beyond traditional research centers to make clinical studies more accessible, allowing medical research organizations to overcome the barriers and inefficiencies associated with conventional clinical trial models. Its mission centers on placing patients at the forefront, ensuring that clinical research is designed to meet the needs of diverse populations globally.

Matternet

Series B in 2020
Matternet is a prominent developer of commercial drone delivery systems aimed at urban and suburban environments. The company offers the Matternet M2 drone along with its proprietary software platform, which allows for automated package exchange and efficient logistics operations. Matternet has established itself as a pioneer in the industry, being the first to gain authorization for commercial Beyond Visual Line of Sight (BVLOS) drone operations in Switzerland in 2017. In collaboration with logistics partners like UPS, Matternet launched drone delivery services in the U.S. in 2019, marking the beginning of revenue-generating drone delivery operations in the country. The Matternet M2 drone achieved significant regulatory milestones, becoming the first drone delivery system to be certified by the Federal Aviation Administration (FAA) in 2022. To date, Matternet's technology has facilitated over 20,000 commercial flights, demonstrating its capability in building and operating comprehensive drone logistics networks for transporting goods.

Augmedix

Series B in 2019
Augmedix, Inc. is a healthcare technology company based in San Francisco, California, with additional offices in Menlo Park and Dhaka, Bangladesh. Founded in 2012, Augmedix specializes in remote medical documentation and live clinical support through its cloud-based platform. The application transforms natural clinician-patient conversations into organized medical notes in real time, allowing healthcare providers to focus more on patient care and reducing the administrative burden associated with electronic health record documentation. By partnering with hospitals and health systems, Augmedix enhances clinical efficiency and decision-making, ultimately improving operational and financial outcomes. The platform is designed for use by both large healthcare organizations and individual practitioners, charging service fees for access to its remote documentation and clinical support services.

IVX Health

Series C in 2019
IVX Health specializes in providing infusion and injection therapy for patients with complex chronic conditions, including rheumatoid arthritis, Crohn's disease, multiple sclerosis, lupus, and psoriasis. The company operates clinics that offer biologic injections and infusions in a private, comfortable environment. Located within the communities they serve, IVX Health centers prioritize convenience with flexible scheduling options, including evenings and weekends. Each center features private suites designed for patient comfort, equipped with high-speed Wi-Fi, flat-screen TVs, and recliners that accommodate guests. In certain locations, IVX Health operates under the brand Infusion Express, serving areas such as Kansas City, Philadelphia, Chicago, and San Francisco.

Echo

Acquisition in 2019
Echo, we believe health is about people, not pills. That’s why we’ve created a new kind of pharmacy. One that comes to you, not the other way around. We start with being brilliant at fulfilling prescriptions because getting people taking the right medicine is the first step in staying well. But there’s more we can do. It’s not just patients we support, its partners. Together with other like-minded pharmacies, GPs and prescribing services we deliver even more positive experiences. Ultimately, we want to help patients understand and do more for themselves, so together they can make the right decisions with their GPs. And when it comes time to improve our health, we all know more Technology should make the future of health care more human. So ours comes packed with care.

AllyAlign Health

Corporate Round in 2019
AllyAlign Health operates as a care management company dedicated to supporting patients with chronic and complex medical conditions. Founded in 2013 and based in Glen Allen, Virginia, the company offers an active care management platform that facilitates real-time, collaborative care across various boundaries. This platform connects patients with care teams, providers, and community-based services, ensuring access to essential health information, care plans, and benefits necessary for informed decision-making. Users can easily view, share, create, and update information according to their roles and responsibilities, with mobile and web-based options enhancing accessibility for patients and their families. A central, HIPAA-compliant database consolidates information from multiple sources, including electronic health records and lab tests, while semantic data modeling provides meaningful clinical insights.

Xealth

Series A in 2019
Xealth Inc. operates a digital health prescribing platform that allows clinicians to integrate, prescribe, and monitor digital health tools directly from electronic health record (EHR) workflows. Founded in 2016 and based in Seattle, Washington, the platform facilitates patient engagement by enabling care teams to order appropriate digital health tools and programs, which can be sent to patients via email or patient portals. In addition to managing digital health prescriptions, the platform supports patient education and offers non-clinical services such as ride shares and food delivery. This comprehensive approach allows clinicians to monitor patient activity and engagement, ultimately enhancing the overall effectiveness of digital health initiatives within healthcare systems.

Aetion

Series B in 2019
Aetion, Inc. is a healthcare analytics company that specializes in generating real-world evidence (RWE) through its Aetion Evidence Platform. This platform analyzes data from diverse clinical and financial interactions within the healthcare system, including claims, electronic health records, and clinical trials. By utilizing its patented rapid-cycle analytics technology, Aetion provides valuable insights to life sciences companies, payers, and healthcare providers, enabling them to assess the effectiveness and value of medical treatments. This facilitates collaboration among stakeholders to make informed decisions regarding patient care that is both clinically effective and cost-efficient. Founded in 2012 and headquartered in New York City, Aetion has established partnerships with various investors and organizations, including a strategic collaboration with McKesson. The company caters to a global clientele, including biopharmaceutical firms and academic institutions.

OncoHealth

Series B in 2018
OncoHealth specializes in oncology benefits management, offering a range of services designed to support health plans, employers, providers, patients, and life science researchers in managing the complexities of cancer care. Its offerings include prior authorization services, clinical decision support, physician education, expert peer review, and oncology network evaluation and optimization consulting. Additionally, OncoHealth provides MATIS, a clinical decision support software that employs evidence-based analytics for evaluating cancer treatment and benefits management in the United States and Puerto Rico. The company aims to alleviate the physical, mental, and financial burdens associated with cancer through technology-driven solutions and real-world data. Founded in 2009, OncoHealth is headquartered in Atlanta, Georgia, with an additional location in Plantation, Florida.

Pharmapacks

Series A in 2018
Pharmapacks is an e-commerce company based in Islandia, New York, that specializes in health and beauty products, including multivitamins, nutritional supplements, personal care, and pet care items. Founded in 2010 as a brick-and-mortar pharmacy, Pharmapacks now operates a proprietary tech platform that provides brands with comprehensive logistics, fulfillment, marketing, and sales solutions. The company sells products directly to consumers via its own website, Pharmapacks.com, as well as through partner sites such as Amazon, Walmart.com, and eBay. Pharmapacks also serves as a launchpad for emerging brands, offering selected lesser-known brands access to its extensive consumer base and e-commerce capabilities. This strategic approach helps to connect consumers with brands while maintaining competitive pricing in the online marketplace.

Propeller Health

Corporate Round in 2018
Propeller Health is a mobile platform that offers sensors, mobile apps, analytics, and services to support respiratory health management. The HIPAA compliant platform stores users’ data in a cloud computing infrastructure. The Propeller sensor and mobile application help users learn more about and better manage their asthma, COPD, and respiratory disease. The Propeller sensor attaches to users’ inhalers and wirelessly syncs with their smartphones. It tracks their triggers and symptoms and sends personalized feedback and education to their phones based on the symptoms. Users can see how often they use the medication, and set up medication reminders and alerts. Propeller community enables users to share their Propeller data with their physician and family members. Propeller Health is backed by Safeguard Scientifics, The Social+Capital Partnership, California HealthCare Foundation, and other investors. The platform works with organizations such as Dignity Health, Wyckoff Heights Medical Center, Amerigroup Florida, and the City of Louisville. The system has been featured in The Economist, Washington Post, Fast Company, Wired, and Scientific American. Propeller Health has received TEDMED Innovation Showcase, White House Champion of Change, and Bluetooth Breakthrough Product awards. Propeller Health was launched by David Van Sickle, Greg Tracy, and Mark Gehring and its operations are based in Wisconsin, United States.

Medical Specialties Distributors

Acquisition in 2018
Medical Specialties Distributors, LLC is a full-service distributor of healthcare products primarily serving the home infusion, specialty pharmacy, and oncology markets. Founded in 1984 and based in Stoughton, Massachusetts, the company offers a wide range of products, including infusion pumps, IV supplies, pharmaceuticals, and various medical surgical products. They manufacture several specialized kits and devices, such as dressing change kits and IV administration sets, and provide additional services like biomedical equipment rental, maintenance, and repair. The company also supports clients with equipment management software and online training programs to enhance product utilization and operational efficiency. Medical Specialties Distributors operates a national network of distribution centers and an online ordering platform, with additional locations in Phoenix, Arizona; Bedford, Ohio; Gurnee, Illinois; and St. Louis, Missouri. As of June 2018, it operates as a subsidiary of McKesson Corporation.

Kyruus

Corporate Round in 2018
Kyruus, Inc. is a Boston-based company that develops web-based software solutions aimed at optimizing physician networks for hospitals, health systems, and life science companies. Founded in 2010, Kyruus offers a suite of analytically driven products designed to enhance provider search and scheduling, ensuring that patients are matched with the most suitable healthcare providers. Key offerings include Kyruus Passport, which allows physicians to track their activity and productivity, and Kyruus Profiles, which enables administrators to analyze physician performance metrics. Additionally, the company provides Kyruus MDSeekyr, a platform for identifying high-value providers, and Kyruus Insight Reports, which help executives evaluate network activity and performance trends. By leveraging a proprietary provider data management platform, Kyruus enhances patient engagement and aligns provider supply with patient demand, ultimately improving the overall healthcare experience. Kyruus also maintains offices in San Francisco and New York.

Accolade

Series F in 2018
Accolade, Inc. is a technology-driven company that offers solutions to help individuals navigate the complexities of the healthcare system and workplace benefits in the United States. The company provides a cloud-based platform complemented by support from a team of health assistants and clinicians, including nurses and behavioral health specialists. Accolade's services are primarily aimed at employers who seek to enhance the healthcare experience for their employees and their families. By focusing on personalized health and benefits solutions, Accolade aims to improve healthcare outcomes while managing costs and increasing employee engagement. Founded in 2007, Accolade is headquartered in Plymouth Meeting, Pennsylvania.

RxTPL

Acquisition in 2018
RxTPL is a pharmaceutical company that provides logistic management, graphics, marketing, IT capabilities, and order-to-cash services.

Well.ca

Acquisition in 2017
Well.ca Inc. is an online retailer specializing in health and wellness products, offering a wide range of items including baby and kids' products, beauty and skincare, personal care, diet and fitness, medicine, vitamins, and pet supplies. Established in 2008 and based in Guelph, Canada, the company serves customers throughout Canada and the continental United States. Well.ca aims to provide a straightforward and convenient shopping experience, featuring quick shipping and competitive pricing. As of December 2017, it operates as a subsidiary of McKesson Canada Corporation.

RxCrossroads

Acquisition in 2017
RxCrossroads Specialty Solutions specializes in pharmaceutical distribution services, focusing on enhancing patient access to therapies. The company offers a comprehensive suite of customized services designed to support both patients and healthcare providers. By streamlining access to medications, including specialty, generic, and bio-similar drugs, RxCrossroads aims to facilitate the commercial success of pharmaceuticals in the market. Their commitment to individualized support helps to differentiate their clients' products, ultimately improving patient outcomes and ensuring that therapies reach those in need.

IVX Health

Series B in 2017
IVX Health specializes in providing infusion and injection therapy for patients with complex chronic conditions, including rheumatoid arthritis, Crohn's disease, multiple sclerosis, lupus, and psoriasis. The company operates clinics that offer biologic injections and infusions in a private, comfortable environment. Located within the communities they serve, IVX Health centers prioritize convenience with flexible scheduling options, including evenings and weekends. Each center features private suites designed for patient comfort, equipped with high-speed Wi-Fi, flat-screen TVs, and recliners that accommodate guests. In certain locations, IVX Health operates under the brand Infusion Express, serving areas such as Kansas City, Philadelphia, Chicago, and San Francisco.

Truveris

Series D in 2017
Truveris brings transparency to the prescription drug ecosystem through data-driven innovations. Truveris’ platform offers customers – from the individual patient to employers, retailers, pharmacy benefits stakeholders, and manufacturers – the data and insights they need to effectively and efficiently manage rising costs and market access challenges. Based in Manhattan, Truveris is backed by Canaan Partners, New Leaf Venture Partners, Tribeca Venture Partners, New Atlantic Ventures and First Round Capital.

intraFUSION

Acquisition in 2017
intraFUSION™ has provided the solution for physicians and their patients who need outpatient intravenous therapy. As the single source manager for all aspects of office based infusion services, they lead the way in outpatient infusion management by affording a higher level of patient care and creating a new source of revenue for the physician. With years of infusion management experience, their team can provide you with best practices and tools to have a successful physician based infusion center.

Carena

Series E in 2017
Carena is a Seattle-based team of medical, technology, and consumer service professionals committed to delivering the best possible healthcare experience to every patient. 24 hours a day. 365 days a year.

Unforgettable.org

Venture Round in 2017
Unforgettable’s mission is to improve the lives’ of all those affected by dementia worldwide and to become the leading global brand destination for life-changing dementia products and services. We are well funded by the UK’s leading social impact investors and Mckesson Ventures. Mckesson is the world’s largest healthcare company. We are a B Corp and believe that business should be a force for good. Unforgettable.org is the most visited dementia product specialist online and the world’s best marketplace of dementia products and services with over 1000 products to help those with dementia do the things we take for granted. And now in partnership with Lloyds Pharmacy, we are the first to bring dementia products to the high street – improving access and raising awareness of dementia products for the people who need them the most.

SHYFT

Series B in 2017
SHYFT Analytics, Inc. specializes in providing cloud-based data management and analytics solutions tailored for the life sciences industry, both in the United States and internationally. The company’s platform integrates clinical and commercial data, enabling life sciences organizations to derive patient-centric intelligence and analytics. This functionality supports various operational needs, including sales strategies, market access, and product launches, effectively shortening development cycles and enhancing the likelihood of successful commercialization. SHYFT offers specialized solutions such as sales insights, market intelligence for product launches, and integrated data for rare diseases. The organization also provides services in launch and commercial analytics, clinical operations, and insight-driven design. Founded in 2002 and based in Waltham, Massachusetts, SHYFT operates as a subsidiary of Medidata Solutions and has a strategic partnership with PAREXEL International.

CoverMyMeds

Acquisition in 2017
CoverMyMeds is a free website and suite of integrated workflow tools that helps physicians and pharmacists complete prior authorization (PA) and other insurance coverage determination forms for any drug and almost all drug plans. PA is the process used by insurance companies to approve or reject prescriptions based on plan formulary. CoverMyMeds makes money by partnering with pharmaceutical manufacturers to improve patient access to branded medications.

Augmedix

Venture Round in 2016
Augmedix, Inc. is a healthcare technology company based in San Francisco, California, with additional offices in Menlo Park and Dhaka, Bangladesh. Founded in 2012, Augmedix specializes in remote medical documentation and live clinical support through its cloud-based platform. The application transforms natural clinician-patient conversations into organized medical notes in real time, allowing healthcare providers to focus more on patient care and reducing the administrative burden associated with electronic health record documentation. By partnering with hospitals and health systems, Augmedix enhances clinical efficiency and decision-making, ultimately improving operational and financial outcomes. The platform is designed for use by both large healthcare organizations and individual practitioners, charging service fees for access to its remote documentation and clinical support services.

SHYFT

Series B in 2016
SHYFT Analytics, Inc. specializes in providing cloud-based data management and analytics solutions tailored for the life sciences industry, both in the United States and internationally. The company’s platform integrates clinical and commercial data, enabling life sciences organizations to derive patient-centric intelligence and analytics. This functionality supports various operational needs, including sales strategies, market access, and product launches, effectively shortening development cycles and enhancing the likelihood of successful commercialization. SHYFT offers specialized solutions such as sales insights, market intelligence for product launches, and integrated data for rare diseases. The organization also provides services in launch and commercial analytics, clinical operations, and insight-driven design. Founded in 2002 and based in Waltham, Massachusetts, SHYFT operates as a subsidiary of Medidata Solutions and has a strategic partnership with PAREXEL International.

HealthQx

Acquisition in 2016
HealthQX specializes in Value-based Payment (VBP) analytic software solutions for health plans and providers. Its VBP analytics platform, ClarityQx, provides the capabilities to design, implement, and monitor the on-going performance of payment models such as episodic, bundled, or accountable care arrangements. The company was founded in 2012 and is based in King Of Prussia, Pennsylvania.

Evariant

Series C in 2016
Evariant, Inc. is a healthcare technology company based in Farmington, Connecticut, founded in 2008. It provides a comprehensive platform designed to assist healthcare organizations in optimizing patient acquisition and retention while improving engagement with both patients and physicians. Evariant's solutions include tools for understanding patient demographics, managing marketing campaigns, and fostering two-way communication. The company offers a range of services, including analytics for tracking physician referral patterns, relationship management platforms for collaboration with healthcare providers, and recruitment tools for enhancing physician outreach. Additionally, Evariant provides digital media services, project management consulting, and a marketplace for healthcare analytics products. With a strong client base that includes over 1,000 hospitals nationwide, Evariant aims to drive growth and improve healthcare delivery by leveraging actionable intelligence and advanced data analytics.

Vantage Oncology

Acquisition in 2016
Vantage Oncology, Inc., offers a comprehensive development, implementation and management solution for radiation oncology. The company was created in response to the growing need among cancer patients, hospitals and physicians for accessible and advanced radiation treatment therapies. Vantage encourages joint venture ownership opportunities that empower physicians to maintain control of their practice while leveraging the strength of the company's network. Vantage also provides joint venture ownership opportunities for hospitals interested in maximizing the significant benefits created by a strong radiation oncology department.

Rexall

Acquisition in 2016
Rexall Health is an industry-leading healthcare management and technology firm that has been providing customized, value-added health benefit claims management and plan administrative services to Canadian corporations and other health benefit plan sponsors for over 30 years.

PokitDok

Venture Round in 2016
PokitDok, Inc. is a provider of cloud-based web services that facilitate the integration of healthcare transactions into various applications and products. The company offers a platform that supports a range of services, including eligibility checks, claims submissions, appointment scheduling, payment processing, and medical procedural code reconciliation. Through its application programming interface (API), PokitDok also provides healthcare providers with information on cash costs for services. Its solutions are utilized by hospital systems, technology providers, and developers to enhance workflows, reduce costs, and analyze business patterns using big data. Additionally, PokitDok features an e-commerce storefront that allows healthcare practitioners to market their services and enables consumers to pay for treatment in advance via its website or mobile app. Founded in 2011, PokitDok is headquartered in San Mateo, California, with an additional office in Charleston, South Carolina.

Komodo Health

Series A in 2016
Komodo Health Inc. is a healthcare technology company that specializes in providing real-time healthcare intelligence and transparency through its innovative platform. Founded in 2014 and based in New York, with an additional office in San Francisco, the company offers a suite of software solutions, including its Healthcare Map, which tracks patient outcomes across the healthcare system. The platform utilizes advanced data science techniques and artificial intelligence to deliver insights that empower various stakeholders in the healthcare sector, including life science companies, payers, and providers. Key products such as Aperture, Pulse, and Serenity facilitate the analysis of complex healthcare connections, alert users to influence disease burden positively, and explore patient cohorts for deeper insights. By enabling a more cost-effective and value-driven healthcare system, Komodo Health aims to set a new standard for real-world data and analytics in the industry.

RetraceHealth

Seed Round in 2016
RetraceHealth, Inc. operates an online platform that facilitates urgent and routine healthcare through video visits and in-person home visits. The platform focuses on providing services in preventive care, pediatric care, primary care, and management of chronic conditions such as high blood pressure and diabetes. Patients can access care via video visits in Minnesota and Wisconsin, while home visits are available in the Twin Cities metro area and other locations. Founded in 2013 and based in Minneapolis, Minnesota, RetraceHealth aims to deliver high-quality primary care that is both personal and affordable, offering services comparable to those found in traditional clinics but delivered directly to patients' homes. The company emphasizes accessible care options, connecting patients with trusted clinical professionals through technology-driven solutions.

PokitDok

Series B in 2015
PokitDok, Inc. is a provider of cloud-based web services that facilitate the integration of healthcare transactions into various applications and products. The company offers a platform that supports a range of services, including eligibility checks, claims submissions, appointment scheduling, payment processing, and medical procedural code reconciliation. Through its application programming interface (API), PokitDok also provides healthcare providers with information on cash costs for services. Its solutions are utilized by hospital systems, technology providers, and developers to enhance workflows, reduce costs, and analyze business patterns using big data. Additionally, PokitDok features an e-commerce storefront that allows healthcare practitioners to market their services and enables consumers to pay for treatment in advance via its website or mobile app. Founded in 2011, PokitDok is headquartered in San Mateo, California, with an additional office in Charleston, South Carolina.

ClearCare

Series C in 2015
ClearCare is the industry leading home care technology platform and has raised over $75MM in venture capital to date including a $60MM round from Battery Ventures in August 2016. Our rapid growth in customers and revenue is driven by our innovative SaaS platform that helps manage all home care agency business functions, including scheduling, billing, payroll, senior-to-caregiver matching, CRM, HR, reporting, and point-of-care management. ClearCare' s web-based platform solves problems for all of the constituents involved in home care: family members, caregivers, seniors, agency staff and the healthcare community. Healthcare is moving to the home with new technologies in remote monitoring, telemedicine, remote diagnostics, and medication compliance. In terms of cost, outcomes, and quality of life, no population stands to benefit from these developments more than seniors who are the largest consumers of healthcare. ClearCare, with its customers, is uniquely positioned to deliver transformative healthcare solutions that bend the cost curve for the world's most expensive patients. Learn more about us here: www.clearcareonline.com

Kyruus

Series C in 2015
Kyruus, Inc. is a Boston-based company that develops web-based software solutions aimed at optimizing physician networks for hospitals, health systems, and life science companies. Founded in 2010, Kyruus offers a suite of analytically driven products designed to enhance provider search and scheduling, ensuring that patients are matched with the most suitable healthcare providers. Key offerings include Kyruus Passport, which allows physicians to track their activity and productivity, and Kyruus Profiles, which enables administrators to analyze physician performance metrics. Additionally, the company provides Kyruus MDSeekyr, a platform for identifying high-value providers, and Kyruus Insight Reports, which help executives evaluate network activity and performance trends. By leveraging a proprietary provider data management platform, Kyruus enhances patient engagement and aligns provider supply with patient demand, ultimately improving the overall healthcare experience. Kyruus also maintains offices in San Francisco and New York.

UDG Healthcare

Acquisition in 2015
UDG Healthcare is a Dublin-based provider of healthcare advisory, communications, commercial, clinical, and packaging services. The company operates through two main divisions: Ashfield and Sharp. Ashfield delivers commercial and medical services, offering advisory, medical, marketing, communications, and patient engagement solutions throughout the lifecycle of a drug. Sharp focuses on packaging services, ensuring that healthcare products are efficiently packaged for market delivery. With a workforce of approximately 8,000 employees across 23 countries, UDG Healthcare specializes in innovative, outsourced solutions that help healthcare companies bring their products to market effectively and efficiently.

Accolade

Series E in 2015
Accolade, Inc. is a technology-driven company that offers solutions to help individuals navigate the complexities of the healthcare system and workplace benefits in the United States. The company provides a cloud-based platform complemented by support from a team of health assistants and clinicians, including nurses and behavioral health specialists. Accolade's services are primarily aimed at employers who seek to enhance the healthcare experience for their employees and their families. By focusing on personalized health and benefits solutions, Accolade aims to improve healthcare outcomes while managing costs and increasing employee engagement. Founded in 2007, Accolade is headquartered in Plymouth Meeting, Pennsylvania.

PipelineRx

Venture Round in 2015
PipelineRx is a multi-state organization based in San Francisco, California, focused on telepharmacy and medication management. Founded in 2009 by Brian Roberts, the company develops a cloud-based platform that enhances pharmacy and patient care by utilizing telemedical technology. This platform reviews and verifies medication orders while documenting clinical interventions, allowing hospitals to improve operational efficiencies and clinical outcomes. PipelineRx also emphasizes leadership development and offers online community services tailored for hospital and retail pharmacies.

Carena

Series D in 2015
Carena is a Seattle-based team of medical, technology, and consumer service professionals committed to delivering the best possible healthcare experience to every patient. 24 hours a day. 365 days a year.

Celesio

Acquisition in 2013
Celesio AG, an international trading company, provides logistics and services in the pharmaceutical and healthcare sector in 16 countries worldwide. The company operates through two divisions: Patient and Consumer Solutions, and Pharmacy Solutions. The Patient and Consumer Solutions division offers prescription and non-prescription pharmaceuticals, History Celesio AG was founded by Franz Ludwig Gehe in 1835 in Dresden. The company was formerly known as GEHE AG and changed its name to Celesio AG in April 2003.

PSS World Medical

Acquisition in 2013
An American distributor of medical products, equipment, billing services and pharmaceutical related products

Emendo

Acquisition in 2012
Emendo’s CapPlan solution enables over 40 hospitals throughout New Zealand, Australia, Canada and the UK to forecast patient demand and plan resourcing. Emendo’s customers report operational efficiencies as well as significant savings ranging from hundreds of thousands to millions of dollars per year. In 2009, the CapPlan implementation at Bedford NHS Trust in the United Kingdom was named winner of the “Adopt, Adapt and Improve” category of the national Health and Social Care Awards. Based in Christchurch, New Zealand, Emendo was founded in 2002 by Nick Burns and Bart Visscher.

MED3000

Acquisition in 2012
MED3000 is a healthcare management company based in Pittsburgh, Pennsylvania, established in 1995. It specializes in developing technology solutions and services that enhance healthcare operations. The company's offerings include billing and revenue cycle management, electronic health records, practice management, coding and compliance, and proactive patient outreach. Additionally, MED3000 provides services related to EMS billing and data warehousing. In October 2012, MED3000 was acquired by McKesson, further expanding its reach in the healthcare sector.

MedVentive

Acquisition in 2012
MedVentive provides leading-edge technology solutions that enable physician groups, integrated delivery systems, health plans and self-insured employers to effect meaningful and measurable change in the quality and cost of the care they deliver to patients. Founded in 1997 by physicians, MedVentive has been at the forefront of the development of innovative and clinically sophisticated solutions to reduce healthcare costs and improve healthcare quality.

peerVue

Acquisition in 2012
Since its inception in 2002, peerVue has been redefining the healthcare IT market with intelligent workflow and communication solutions that enable healthcare organizations to improve patient care, while also reducing risk and simplifying processes. With a passion for technology and innovation, peerVue was established to solve critical workflow and communication gaps in healthcare that jeopardize patient safety and render imaging organizations inefficient. peerVue delivers solutions worldwide with dozens of integrations to leading healthcare imaging and IT across multiple specialties, including radiology, mammography, cardiology and pathology.

Drug Trading

Acquisition in 2012
Drug Trading Company Limited ("Drug Trading"), the independent banner business of Katz Group Canada Inc. ("Katz Group"), and Medicine Shoppe Canada Inc., the franchise business of Katz Group. Katz Group is a privately-owned company that operates an integrated retail pharmacy network in Canada.

Portico Systems

Acquisition in 2011
Portico's technology enables healthcare organizations to design, build, service and provide value-based reimbursement to their complex provider networks. It also provides the ability to align and automate key network management activities including, provider enrollment, credentialing, contracting and pricing.

US Oncology

Acquisition in 2010
The US Oncology Network is one of the nation's largest networks of integrated, community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care. A physician-led organization, The US Oncology Networks unites like-minded physicians and clinicians around a common vision of improving patient outcomes and quality of life. Leveraging healthcare information technology, shared best practices, evidence-based guidelines and quality measurements, physicians within The US Oncology Network are pioneering new ways to achieve this vision. The US Oncology Network is committed to strengthening patient access to integrated care in local communities across the nation, including collaboration with a variety of payers, hospitals and academic institutions. The US Oncology Network is supported by McKesson Specialty Health, a division of McKesson Corporation focused on empowering a vibrant and sustainable community patient care delivery system.

EN-Chart Scanning Program

Acquisition in 2008
A provider of computer-assisted facility coding and compliance solutions for emergency department visits.

McQueary Brothers

Acquisition in 2008
McQueary Bros. Drug Company, a Springfield, Missouri–based regional distributor of pharmaceutical, health, and beauty products to more than 400 independent pharmacies in Missouri, Arkansas, Illinois, Kansas, Oklahoma, Nebraska, and Iowa.

Vivalog Technologies

Acquisition in 2008
Vivalog Technologies provides knowledge management software solutions to hospitals and research institutions.

Rosebud Solutions

Acquisition in 2008
Rosebud Solutions, LLC designs, develops, markets, and supports a suite of workflow process improvement software programs.

Oncology Therapeutics Network

Acquisition in 2007
Oncology Therapeutics Network is a physician services company. It provides technology solutions, distribution services, practice management tools, and educational programs. The company offers brand and generic pharmaceuticals; Lynx Technology Platform, a charge capture and inventory management and reporting tool; Lynx EMR, a functional subscription-based electronic medical record software service; financial solutions; Web-based portal that manages various clinics' critical processes; and home delivery services for self-administered medications, as well as manages benefits investigation and insurance claims. Oncology Therapeutics Network was founded in 1990 and is headquartered in San Francisco, California.

Practice Partner

Acquisition in 2007
Practice Partner, Inc. provides electronic health record and practice management solutions.

Per-Se Technologies

Acquisition in 2007
Per-Se Technologies is a provider of healthcare business and information technology services that aims to assist physicians and hospitals in maximizing their income potential. The company offers technology solutions designed to streamline reimbursement processes, enabling healthcare providers to receive payments more quickly. By improving financial operations, Per-Se Technologies allows healthcare businesses to concentrate more on patient care, thus enhancing overall service delivery in the healthcare sector.

RelayHealth

Acquisition in 2006
RelayHealth is a provider of online healthcare communication services that facilitates secure and convenient information exchange among various healthcare stakeholders, including patients, providers, pharmacies, payors, and pharmaceutical manufacturers. The company offers a range of services such as ePrescribing, online refills, access to lab results, reimbursable online visits, and online bill payments. By enabling consistent connectivity among medical companies, doctors, and patients, RelayHealth aims to streamline interactions within the healthcare system. This connectivity ultimately contributes to improved patient care, faster access to necessary services, reduced costs, and enhanced operational efficiency for healthcare providers.

HealthCom Partners

Acquisition in 2006
A leading provider of patient billing solutions.

Sterling Medical Services

Acquisition in 2006
Founded in 1992, Sterling Medical Services, LLC is a national provider and distributor of medical disposable supplies and health management services to the homecare market. Our customers include managed care organizations and other health insurance plans, home health nursing agencies, physician practices, rehab facilities, out-patient clinics, hospital discharge nursing, and individual patients.

NDCHealth

Acquisition in 2006
NDC Health provides healthcare information solutions. Its products and services comprise point-of-care systems, electronic prescription connections, patient scheduling, claims processing, billing, and other financial management. The company’s solutions address various administrative, clinical, and operational informational needs. It serves physicians, hospitals, pharmaceutical manufacturers, retail pharmacies, and managed care organizations.

D & K Healthcare Resources

Acquisition in 2005
D&K Healthcare Resources, Inc. operates as a wholesale drug distributor in the United States.

Medcon

Acquisition in 2005
Medcon is a global leader in cardiac image and information management solutions, devoted exclusively to optimizing the quality and cost-effectiveness of healthcare. Medcon ensures rapid access to complete and accurate images and information over local or remote networks, so cardiologists can provide the ultimate in care to patients. Their software applications are developed using cutting-edge technology and support industry standards. Medcon has over 300 installations worldwide.

Moore Medical

Acquisition in 2004
Moore Medical is a multi-channel marketer and distributor of medical, surgical, and pharmaceutical products, serving nearly 100,000 health care practices and facilities in non-hospital settings across the nation. Its diverse customer base includes physicians, emergency medical technicians, schools, correctional institutions, municipalities, and occupational health professionals. The company has been operational for 55 years and utilizes various marketing channels, including direct mail, specialized telephone support, field sales representatives, customer community affiliates, and online platforms, to reach its clients effectively. By providing tailored solutions to specialty practice communities, Moore Medical plays a vital role in the healthcare supply chain outside of traditional hospital environments.

A.L.I. Technologies

Acquisition in 2002
A.L.I. provides medical imaging solutions which are designed to streamline access to diagnostic information, automate clinical workflow and eliminate the need for film.

MediVation

Acquisition in 2000
MediVation’s electronic provider-patient interface, which enables providers to transfer data to secure patient Web pages, into its clinical and administrative applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.